American Oriental Bioengineering Inc (AOBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Sales | 52,002 | 83,365 | 91,533 | 77,296 | 53,750 |
| Cost of Goods | 26,926 | 40,967 | 44,251 | 37,456 | 25,513 |
| Gross Profit | 25,076 | 42,398 | 47,282 | 39,840 | 28,237 |
| Operating Expenses | 20,459 | 37,422 | 38,562 | 31,211 | 22,380 |
| Operating Income | 5,544 | 5,943 | 8,971 | 9,086 | 6,370 |
| Interest Expense | 1,514 | 3,073 | 1,456 | 1,371 | 0 |
| Other Income | -96 | 1,471 | -909 | -201 | -1,436 |
| Pre-tax Income | 3,934 | 4,341 | 6,606 | 7,514 | 4,934 |
| Income Tax | 3,125 | 2,757 | 2,366 | 2,396 | 1,816 |
| Net Income Continuous | 809 | 1,584 | 4,240 | 5,118 | 3,118 |
| Minority Interests | 3 | -8 | -8 | -7 | -5 |
| Net Income | $806 | $1,592 | $4,247 | $5,124 | $3,123 |
| EPS Basic Total Ops | 10.00 | 20.00 | 60.00 | 70.00 | 40.00 |
| EPS Basic Continuous Ops | 10.79 | 21.14 | 56.58 | 68.47 | 41.74 |
| EPS Diluted Total Ops | 10.00 | 15.00 | 60.00 | 70.00 | 40.00 |
| EPS Diluted Continuous Ops | 10.64 | 27.54 | 55.81 | 67.47 | 34.85 |
| EBITDA(a) | $8,920 | $9,191 | $12,380 | $12,591 | $9,841 |